UTI Asset Management Company Limited (UTI AMC) has reported robust financial results for the first quarter, showcasing significant growth in profits and assets under management (AUM).

Standalone Performance

UTI AMC's standalone profit for Q1 reached ₹216.13 crore, marking a substantial 16% increase from ₹185.81 crore in the same quarter last year. The company's total income rose to ₹438.31 crore, up from ₹390.01 crore year-over-year, indicating strong revenue growth.

Consolidated Results

On a consolidated basis, the company reported a profit attributable to owners of ₹236.85 crore for Q1. While this represents a 7% decrease from ₹254.17 crore in the previous year, it's important to note that the company's core profit after tax increased by 4% year-over-year to ₹122 crore.

Assets Under Management

UTI AMC's total group AUM stood at an impressive ₹21,93,215 crore as of June 30. The company's mutual fund quarterly average AUM (QAAUM) reached ₹3,60,867 crore, reflecting a robust 16.15% year-over-year growth.

Business Highlights

• Equity assets (active + passive) contributed 69% to UTI MF's total average AUM.
• The company maintained a strong presence across 699 districts in India.
• Total live folios stood at 1.35 crore as of June 30.
• Gross inflow mobilized through Systematic Investment Plans (SIPs) for the quarter was ₹2,260.98 crore.
• SIP AUM grew by 16.90% year-over-year to ₹42,195.93 crore.

Digital Initiatives

UTI AMC reported significant progress in its digital initiatives, with digital purchase transactions rising to 49.14 lakh, marking a 29.86% increase compared to the same quarter last year.

Subsidiary Loan Approval

In a strategic move, UTI AMC's Board of Directors approved an unsecured working capital loan of up to ₹45 crore to its wholly-owned subsidiary, UTI Alternatives Private Limited (UTI APL). The loan carries an interest rate based on the 1-year SBI MCLR, with quarterly interest payments and is repayable by March 31, 2028.

Management Commentary

Mr. Imtaiyazur Rahman, Managing Director & Chief Executive Officer of UTI AMC, commented on the results: "Q1 has offered a strong start to the financial year both for UTI AMC as well as the mutual fund industry. At the Company level, we have seen a notable growth in AUM and steady SIP inflows depicting a progressive curve in the last quarter."

Dividend Announcement

The Board of Directors has proposed a final dividend of ₹26 per equity share and an additional special dividend of ₹22 per equity share, subject to shareholder approval at the upcoming Annual General Meeting.

UTI AMC's strong Q1 performance, coupled with its strategic initiatives and robust AUM growth, positions the company well for continued success in the asset management industry.

UTI AMC has announced the record date for its final dividend, providing clarity to shareholders regarding their eligibility for the upcoming payout.

Key Details

Clarification and Compliance

UTI AMC has issued a clarification regarding the record date for its final dividend payment. In a filing to the BSE Limited, the company confirmed that the record date has been set in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The clarification comes as a follow-up to the company's earlier communication dated July 9, 2025, which included the Notice of the 22nd Annual General Meeting along with the Annual Report for the financial year ended March 31, 2025.

Importance for Shareholders

The record date is crucial for shareholders as it determines who will be eligible to receive the final dividend. Investors who own UTI AMC shares at the close of business on July 24, 2025, will be entitled to the dividend payout.

Corporate Governance

This timely clarification by UTI AMC demonstrates the company's commitment to transparent communication with its shareholders and compliance with regulatory requirements. By providing clear information about the record date, UTI AMC ensures that all stakeholders are well-informed about the dividend distribution process.

Shareholders and potential investors are advised to take note of this important date as it may impact investment decisions and dividend income planning.